Process modelling has a long and established research tradition, in the context of formally capturing sequences of activities, as well as the involved parties and the exchanged data. It will, without a doubt, continue to play a major role in the context of supporting the development of added-value services industry 4.0. In the medical domain, clinical pathways are a specific form of process modelling. They are an evidence-based response to particular problems and care needs in clinics. Current developers and latest technologies, improve and refine, among others, also the expressivity of clinical pathways. As a result, advanced pathways modelling optimises the treatment procedures in clinics (i.e. by reducing the stay of a patient or the mortality rates). However, as a side-effect of this trend, clinical pathways become increasingly complex and it becomes harder to keep up to date with the latest published processes. In oder to address the challenge of analysing clinical pathways, we provide an approach to capture information about activities and annotate the modelled pathways with references to external data sources. We demonstrate the practical applicability of our approach by using our system to model an actual clinical pathway, and enrich it with metainformation and references to external data sources, such as PubMed. We show the use and expressivity of our data model by querying the captured data.
[1]
Ralf-Detlef Kutsche,et al.
Metamodeling Foundation for Software and Data Integration
,
2009,
UNISCON.
[2]
M. Panella,et al.
Reducing clinical variations with clinical pathways: do pathways work?
,
2003,
International journal for quality in health care : journal of the International Society for Quality in Health Care.
[3]
D. Hindle,et al.
Clinical pathways in 17 European Union countries: a purposive survey.
,
2005,
Australian health review : a publication of the Australian Hospital Association.
[4]
E. James,et al.
What is a clinical pathway? Development of a definition to inform the debate
,
2010,
BMC medicine.
[5]
K. Zander,et al.
Prevalence and use of clinical pathways in 23 countries – an international survey by the European Pathway Association
,
2006
.
[6]
Werner Esswein,et al.
BPMN4CP: Design and implementation of a BPMN extension for clinical pathways
,
2014,
2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[7]
Yike Guo,et al.
Modelling and performance analysis of clinical pathways using the stochastic process algebra PEPA
,
2012,
BMC Bioinformatics.
[8]
K. Zander.
Integrated Care Pathways: Eleven International Trends
,
2002
.